• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MBP
Click for more information
3.23% 3.0¢

METABOLIC PHARMACEUTICALS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Announcements


Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
MBPExercise of PolyNovo OptionPRICE SENSITIVE16/11/09 download Created with Sketch. 89.4KB
MBPPreliminary Final ReportPRICE SENSITIVE28/08/09 download Created with Sketch. 273.63KB
MBPPOH signs agreement with Metabolic Pharmaceuticals LtdPRICE SENSITIVE13/08/09 download Created with Sketch. 18.06KB
MBPMarket UpdatePRICE SENSITIVE10/08/09 download Created with Sketch. 137.05KB
MBPMarket UpdatePRICE SENSITIVE14/05/09 download Created with Sketch. 95.5KB
MBPFirst NovoSorb Patent Granted in AustraliaPRICE SENSITIVE04/03/09 download Created with Sketch. 72.3KB
MBPHalf Yearly Report and AccountsPRICE SENSITIVE26/02/09 download Created with Sketch. 1.03MB
MBP +Metabolic Investment into PolyNovoPRICE SENSITIVE18/12/08 download Created with Sketch. 105.65KB
MBPProposed PolyNovo acquisition terminatedPRICE SENSITIVE01/12/08 download Created with Sketch. 142.61KB
MBPExercise of PolyNovo Option
16/11/09PRICE SENSITIVE download Created with Sketch. 89.4KB
MBPPreliminary Final Report
28/08/09PRICE SENSITIVE download Created with Sketch. 273.63KB
MBPPOH signs agreement with Metabolic Pharmaceuticals Ltd
13/08/09PRICE SENSITIVE download Created with Sketch. 18.06KB
MBPMarket Update
10/08/09PRICE SENSITIVE download Created with Sketch. 137.05KB
MBPMarket Update
14/05/09PRICE SENSITIVE download Created with Sketch. 95.5KB
MBPFirst NovoSorb Patent Granted in Australia
04/03/09PRICE SENSITIVE download Created with Sketch. 72.3KB
MBPHalf Yearly Report and Accounts
26/02/09PRICE SENSITIVE download Created with Sketch. 1.03MB
MBP +Metabolic Investment into PolyNovo
18/12/08PRICE SENSITIVE download Created with Sketch. 105.65KB
MBPProposed PolyNovo acquisition terminated
01/12/08PRICE SENSITIVE download Created with Sketch. 142.61KB
refresh Created with Sketch. REFRESH
 

Top Stories

Reporting wrap: Inghams, Accent, Mayne Pharma

Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
The Rising Tide: How institutional adoption is shaping the future of crypto This year's institutional demand for Bitcoin supports stability & credibility for the asset class. We look at what's happened since crypto ETFs were approved in the US & what that means for Australian investors.
Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt Noronex Limited (ASX:NRX) has kicked off a gravity EM survey at the Damara project in Namibia – part of its earn-in deal with South32.
Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign Strategic Energy Resources is 4 holes into a 40-hole RC drill campaign at its Achilles 1 copper-gold target in the Cobar Basin of NSW.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.